261 related articles for article (PubMed ID: 28427508)
1. Review of current evidence available for guiding optimal Enoxaparin prophylactic dosing strategies in obese patients-Actual Weight-based vs Fixed.
He Z; Morrissey H; Ball P
Crit Rev Oncol Hematol; 2017 May; 113():191-194. PubMed ID: 28427508
[TBL] [Abstract][Full Text] [Related]
2. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
Walker CK; Sandmann EA; Horyna TJ; Gales MA
Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
[TBL] [Abstract][Full Text] [Related]
3. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Adequacy of VTE Prophylaxis Dosing with Enoxaparin for Overweight and Obese Patients on an Orthopedic-Medical Trauma Comanagement Service.
Perrin A; Sheth H; Snyder V; Dailey H; Jovin F; Smith R
South Med J; 2023 Apr; 116(4):345-349. PubMed ID: 37011582
[TBL] [Abstract][Full Text] [Related]
6. Dosing of enoxaparin for venous thromboembolism prophylaxis in obese patients.
Willett KC; Alsharhan M; Durand C; Cooper MR
Ann Pharmacother; 2013 Dec; 47(12):1717-20. PubMed ID: 24301685
[TBL] [Abstract][Full Text] [Related]
7. Increased enoxaparin dosing is required for obese children.
Lewis TV; Johnson PN; Nebbia AM; Dunlap M
Pediatrics; 2011 Mar; 127(3):e787-90. PubMed ID: 21321026
[TBL] [Abstract][Full Text] [Related]
8. Enoxaparin dosing after cesarean delivery in morbidly obese women.
Overcash RT; Somers AT; LaCoursiere DY
Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508
[TBL] [Abstract][Full Text] [Related]
9. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.
Rondina MT; Wheeler M; Rodgers GM; Draper L; Pendleton RC
Thromb Res; 2010 Mar; 125(3):220-3. PubMed ID: 19272635
[TBL] [Abstract][Full Text] [Related]
10. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
Bigos R; Solomon E; Dorfman JD; Ha M
J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
[TBL] [Abstract][Full Text] [Related]
11. Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient.
Bickford A; Majercik S; Bledsoe J; Smith K; Johnston R; Dickerson J; White T
Am J Surg; 2013 Dec; 206(6):847-51, discussion 851-2. PubMed ID: 24070664
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an enoxaparin dosing calculator using burn size and weight.
Faraklas I; Ghanem M; Brown A; Cochran A
J Burn Care Res; 2013; 34(6):621-7. PubMed ID: 24043245
[TBL] [Abstract][Full Text] [Related]
13. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
[TBL] [Abstract][Full Text] [Related]
14. Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients.
Thind T; Heye T; Henson C; Reif R; Jensen HK; Kalkwarf KJ; Bhavaraju A; Robertson R; Jenkins A
Am Surg; 2024 Jun; 90(6):1406-1411. PubMed ID: 38518208
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients.
Yam L; Bahjri K; Geslani V; Cotton A; Hong L
Pharmacotherapy; 2019 Jul; 39(7):749-755. PubMed ID: 31112313
[TBL] [Abstract][Full Text] [Related]
16. Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial.
Bruno AM; Allshouse AA; Campbell HM; Branch DW; Lim MY; Silver RM; Metz TD
Obstet Gynecol; 2022 Oct; 140(4):575-583. PubMed ID: 36075079
[TBL] [Abstract][Full Text] [Related]
17. Single-center Experience with Venous Thromboembolism Prophylaxis for Obese Burn Patients.
McKinzie BP; Nizamani R; Jones S; King B; Williams FN
J Burn Care Res; 2021 May; 42(3):365-368. PubMed ID: 33674883
[TBL] [Abstract][Full Text] [Related]
18. Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.
Pannucci CJ; Hunt MM; Fleming KI; Prazak AM
Plast Reconstr Surg; 2017 Oct; 140(4):815-822. PubMed ID: 28953735
[TBL] [Abstract][Full Text] [Related]
19. Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity.
Freeman A; Horner T; Pendleton RC; Rondina MT
Am J Hematol; 2012 Jul; 87(7):740-3. PubMed ID: 22565589
[TBL] [Abstract][Full Text] [Related]
20. Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations.
Sebaaly J; Covert K
Ann Pharmacother; 2018 Sep; 52(9):898-909. PubMed ID: 29592538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]